Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence
- PMID: 20723932
- DOI: 10.1016/j.juro.2010.06.041
Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence
Abstract
Purpose: Whole mount processing is more resource intensive than routine systematic sampling of radical retropubic prostatectomy specimens. We compared whole mount and systematic sampling for detecting pathological outcomes, and compared the prognostic value of pathological findings across pathological methods.
Materials and methods: We included men (608 whole mount and 525 systematic sampling samples) with no prior treatment who underwent radical retropubic prostatectomy at Vanderbilt University Medical Center between January 2000 and June 2008. We used univariate and multivariate analysis to compare the pathological outcome detection rate between pathological methods. Kaplan-Meier curves and the log rank test were used to compare the prognostic value of pathological findings across pathological methods.
Results: There were no significant differences between the whole mount and the systematic sampling groups in detecting extraprostatic extension (25% vs 30%), positive surgical margins (31% vs 31%), pathological Gleason score less than 7 (49% vs 43%), 7 (39% vs 43%) or greater than 7 (12% vs 13%), seminal vesicle invasion (8% vs 10%) or lymph node involvement (3% vs 5%). Tumor volume was higher in the systematic sampling group and whole mount detected more multiple surgical margins (each p <0.01). There were no significant differences in the likelihood of biochemical recurrence between the pathological methods when patients were stratified by pathological outcome.
Conclusions: Except for estimated tumor volume and multiple margins whole mount and systematic sampling yield similar pathological information. Each method stratifies patients into comparable risk groups for biochemical recurrence. Thus, while whole mount is more resource intensive, it does not appear to result in improved detection of clinically important pathological outcomes or prognostication.
Copyright © 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.J Urol. 2007 Dec;178(6):2385-9; discussion 2389-90. doi: 10.1016/j.juro.2007.08.008. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936849
-
Impact of patient age on biochemical recurrence rates following radical prostatectomy.J Urol. 2007 Nov;178(5):1933-7; discussion 1937-8. doi: 10.1016/j.juro.2007.07.016. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868723
-
Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.J Urol. 2002 Jul;168(1):110-5. J Urol. 2002. PMID: 12050502
-
International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens.Adv Anat Pathol. 2011 Jul;18(4):301-5. doi: 10.1097/PAP.0b013e3182211ce0. Adv Anat Pathol. 2011. PMID: 21654361 Review.
-
The handling and sampling of radical prostatectomy specimens for reporting and research: the Oxford approach.J Clin Pathol. 2012 Dec;65(12):1057-61. doi: 10.1136/jclinpath-2012-200923. Epub 2012 Aug 7. J Clin Pathol. 2012. PMID: 22872704 Review.
Cited by
-
Correlation of histomorphologic findings and partial neurovascular bundle preservation during laparoscopic and robotic radical prostatectomy.J Robot Surg. 2013 Mar;7(1):1-8. doi: 10.1007/s11701-011-0323-2. Epub 2011 Nov 13. J Robot Surg. 2013. PMID: 27000885
-
Prostate cancer detection using combined auto-fluorescence and light reflectance spectroscopy: ex vivo study of human prostates.Biomed Opt Express. 2014 Apr 14;5(5):1512-29. doi: 10.1364/BOE.5.001512. eCollection 2014 May 1. Biomed Opt Express. 2014. PMID: 24877012 Free PMC article.
-
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.Diagn Mol Pathol. 2012 Jun;21(2):61-8. doi: 10.1097/PDM.0b013e31823b6da6. Diagn Mol Pathol. 2012. PMID: 22555088 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical